Bacillus Calmette-Guerin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma

被引:6
|
作者
Aznar Martinez, Laura [1 ]
Lopez Cubillana, Pedro [1 ]
Lopez Abadb, Alicia [2 ]
Vidal Crespo, Natalia [1 ]
Gomez Gomez, Guillermo Antonio [1 ]
机构
[1] Virgen de la Arrixaca Clin Univ Hosp, Dept Urol, Enrique Gallego 17, ES-30120 Murcia, Spain
[2] Univ Murcia, Dept Urol, Murcia, Spain
关键词
Nonmuscle invasive bladder cancer; Immunosuppressed; Kidney transplant; Treatment; RENAL-TRANSPLANT RECIPIENTS; TRANSITIONAL-CELL CARCINOMA; CANCER;
D O I
10.1159/000501108
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Due to their immunosuppressed status, solid organ transplant recipients are a special group of patients with an incidence of bladder cancer greater than the rest of the population, especially in the first 6 years after transplantation. Also, treatment with Bacillus Calmette-Guerin, a reference therapy in nonmuscle invasive high-risk bladder cancer, may be less effective in this group of patients and could cause more adverse effects. However, the data published so far and the experience initiated in the Virgen de la Arrixaca Clinical University Hospital do not support these hypotheses. (C) 2019 S. Karger AG, Basel
引用
收藏
页码:242 / 244
页数:3
相关论文
共 50 条
  • [41] Polyamine-modulated Factor-1 Methylation Predicts Bacillus Calmette-Guerin Response in Patients with High-grade Non-muscle-invasive Bladder Carcinoma
    Alvarez-Mugica, Miguel
    Fernandez-Gomez, Jesus M.
    Cebrian, Virginia
    Fresno, Florentino
    Escaf, Safwan
    Sanchez-Carbayo, Marta
    EUROPEAN UROLOGY, 2013, 63 (02) : 364 - 370
  • [42] Impact of Adjuvant Intravesical Bacillus Calmette-Guerin Treatment on Patients with High-Grade T1 Bladder Cancer
    Novotny, Vladimir
    Froehner, Michael
    Ollig, Johanna
    Koch, Rainer
    Zastrow, Stefan
    Wirth, Manfred P.
    UROLOGIA INTERNATIONALIS, 2016, 96 (02) : 136 - 141
  • [43] A Prospective Comparative Study of Intravesical Bacillus Calmette-Guerin Therapy with the Tokyo or Connaught Strain for Nonmuscle Invasive Bladder Cancer
    Sengiku, Atsushi
    Ito, Masaaki
    Miyazaki, Yu
    Sawazaki, Harutake
    Takahashi, Takeshi
    Ogura, Keiji
    JOURNAL OF UROLOGY, 2013, 190 (01): : 50 - 54
  • [44] Efficacy and Safety of Photodynamic Therapy for Recurrent, High Grade Nonmuscle Invasive Bladder Cancer Refractory or Intolerant to Bacille Calmette-Guerin Immunotherapy
    Lee, Joo Yong
    Diaz, Richilda Red
    Cho, Kang Su
    Lim, Meng Shi
    Chung, Jae Seung
    Kim, Won Tae
    Ham, Won Sik
    Choi, Young Deuk
    JOURNAL OF UROLOGY, 2013, 190 (04): : 1192 - 1199
  • [45] Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model
    Fernandez-Gomez, Jesus
    Madero, Rosario
    Solsona, Eduardo
    Unda, Miguel
    Martinez-Pineiro, Luis
    Gonzalez, Marcelino
    Portillo, Jose
    Ojea, Antonio
    Pertusa, Carlos
    Rodriguez-Molina, Jesus
    Emilio Camacho, Jose
    Rabadan, Mariano
    Astobieta, Ander
    Montesinos, Manuel
    Isorna, Santiago
    Muntanola, Pedro
    Gimeno, Anabel
    Blas, Miguel
    Antonio Martinez-Pineiro, Jose
    JOURNAL OF UROLOGY, 2009, 182 (05): : 2195 - 2203
  • [46] Loss of Heterozygosis on IFN-α Locus is a Prognostic Indicator of Bacillus Calmette-Guerin Response for Nonmuscle Invasive Bladder Cancer
    Cai, Tommaso
    Nesi, Gabriella
    Dal Canto, Maurizio
    Tinacci, Galliano
    Mondaini, Nicola
    Piazzini, Mauro
    Geppetti, Pierangelo
    Bartoletti, Riccardo
    JOURNAL OF UROLOGY, 2010, 183 (05): : 1738 - 1743
  • [47] Association of the commensal urinary microbiome with response to Bacillus Calmette-Guerin (BCG) immunotherapy in nonmuscle invasive bladder cancer.
    Sweis, Randy F.
    Golan, Shay
    Barashi, Nimrod
    Hill, Elle
    Andolfi, Ciro
    Werntz, Ryan P.
    Bloodworth, Jeffrey
    Steinberg, Gary D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [48] The bacillus Calmette-Guerin as immunomodulator in bladder cancer
    Gabriel Vazquez-Lavista, Luis
    Haydee Flores-Balcazar, Christian
    Llorente, Luis
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2007, 59 (02): : 146 - 152
  • [49] Bacillus calmette-guerin (BCG) used for intravesical instillations in the treatment of nonmuscle invasive transitional cell carcinoma (TCC) of the bladder: Does the strain matter?
    Thalmann, G. N.
    Birkhaeuser, F.
    Rentsch, C. A.
    Ochsner, K.
    Studer, U. E.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 61 - 61
  • [50] Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma
    Cugati, Sudha
    Gilhotra, Jagjit Singh
    Lake, Stewart
    Gordon, David L.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 (05): : 494 - 495